733 related articles for article (PubMed ID: 6175395)
21. Tumor-associated antigen for cystadenocarcinomas of the ovary.
Bhattacharya M; Barlow JJ
Natl Cancer Inst Monogr; 1975 Oct; 42():25-32. PubMed ID: 825781
[TBL] [Abstract][Full Text] [Related]
22. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
[TBL] [Abstract][Full Text] [Related]
23. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas.
Sonoda K; Nakashima M; Kaku T; Kamura T; Nakano H; Watanabe T
Cancer; 1996 Apr; 77(8):1501-9. PubMed ID: 8608535
[TBL] [Abstract][Full Text] [Related]
24. Development of hybridoma cells producing monoclonal antibody against human epsilon (epsilon) chain.
Majidi J; Hassan ZM
Hum Antibodies; 2003; 12(3):93-8. PubMed ID: 14646037
[TBL] [Abstract][Full Text] [Related]
25. [Sharing antigenic determinant of colon carcinoma between serous and mucinous tumors of the ovary].
Liu MP; Lu ZT; Chen W
Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):398-400, 444. PubMed ID: 7528120
[TBL] [Abstract][Full Text] [Related]
26. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M
Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557
[TBL] [Abstract][Full Text] [Related]
27. Tumour-associated antigens for cystadenocarcinoma of the ovary.
Barlow JJ; Bhattacharya M
Clin Obstet Gynaecol; 1983 Aug; 10(2):187-96. PubMed ID: 6413113
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibody PR92 with restricted specificity for tumor-associated antigen of prostate and breast carcinoma.
Kim YD; Robinson DY; Tomita JT
Cancer Res; 1988 Aug; 48(16):4543-8. PubMed ID: 3396007
[TBL] [Abstract][Full Text] [Related]
29. Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients.
Haspel MV; McCabe RP; Pomato N; Janesch NJ; Knowlton JV; Peters LC; Hoover HC; Hanna MG
Cancer Res; 1985 Aug; 45(8):3951-61. PubMed ID: 4016762
[TBL] [Abstract][Full Text] [Related]
30. Production and characterization of monoclonal antibodies to bovine immunoglobulin G2.
Srikumaran S; Guidry AJ; Goldsby RA
Am J Vet Res; 1982 Jan; 43(1):21-5. PubMed ID: 7091814
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibody to a human osteogenic sarcoma cell line.
Lizonová A; Blahová S; Bízik J; Grófová M
Arch Geschwulstforsch; 1988; 58(3):151-7. PubMed ID: 3046555
[TBL] [Abstract][Full Text] [Related]
32. Human monoclonal antibody reactive to stomach cancer produced by mouse-human hybridoma technique.
Yoshikawa K; Ueda R; Obata Y; Utsumi KR; Notake K; Takahashi T
Jpn J Cancer Res; 1986 Nov; 77(11):1122-33. PubMed ID: 3098722
[TBL] [Abstract][Full Text] [Related]
33. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
34. Production and characterization of monoclonal antibodies recognizing the alpha-chain subunits of human ia alloantigens.
Adams TE; Bodmer JG; Bodmer WF
Immunology; 1983 Dec; 50(4):613-24. PubMed ID: 6197354
[TBL] [Abstract][Full Text] [Related]
35. Human bladder cancer cell-surface antigens recognized by murine monoclonal antibodies raised against T24 bladder cancer cells.
Masuko T; Abe J; Yagita H; Hashimoto Y
Jpn J Cancer Res; 1985 May; 76(5):386-94. PubMed ID: 3924712
[TBL] [Abstract][Full Text] [Related]
36. Common human melanoma-associated antigen(s) detected by monoclonal antibodies.
Carrel S; Accolla RS; Carmagnola AL; Mach JP
Cancer Res; 1980 Jul; 40(7):2523-8. PubMed ID: 6155995
[TBL] [Abstract][Full Text] [Related]
37. HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells.
Suzuki N; Aoki D; Tamada Y; Susumu N; Orikawa K; Tsukazaki K; Sakayori M; Suzuki A; Fukuchi T; Mukai M; Kojima-Aikawa K; Ishida I; Nozawa S
Gynecol Oncol; 2004 Nov; 95(2):290-8. PubMed ID: 15491748
[TBL] [Abstract][Full Text] [Related]
38. Production of murine monoclonal antibodies against cell-surface antigens of human ovarian carcinoma.
Bhattacharya M; Chatterjee SK; Gangopadhyay A; Barlow JJ
J Surg Oncol; 1985 Dec; 30(4):209-14. PubMed ID: 2417057
[TBL] [Abstract][Full Text] [Related]
39. Human prostate tissue antigens defined by murine monoclonal antibodies.
Starling JJ; Sieg SM; Beckett ML; Wirth PR; Wahab Z; Schellhammer PF; Ladaga LE; Poleskic S; Wright GL
Cancer Res; 1986 Jan; 46(1):367-74. PubMed ID: 2415250
[TBL] [Abstract][Full Text] [Related]
40. Detection of a human sarcoma-associated antigen with monoclonal antibodies.
Brown JM
Cancer Res; 1983 May; 43(5):2113-20. PubMed ID: 6299540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
